Relocation of the European Medicines Agency and the European Banking Authority:Written statement - HCWS263

WS
Department for Exiting the European Union
Made on: 21 November 2017
Made by: Mr Robin Walker (Parliamentary Under Secretary of State for Exiting the European Union)
Commons

Relocation of the European Medicines Agency and the European Banking Authority

On 20 November 2017, the EU27 decided the new host cities of two London based EU Agencies, the European Medicines Agency (EMA) and the European Banking Authority (EBA).

Following a vote in the margins of the General Affairs Council (Art. 50) meeting, it has been announced that the EMA will relocate to Amsterdam; and that the EBA will move to Paris.

The Government values the contribution made by all staff working in the EMA and EBA in supporting the work of the EU. We appreciate that this announcement will affect individual staff, and we encourage the Commission and other EU institutions to recognise the contribution made by all staff, including UK nationals, and honour their commitments to their staff.

We recognise that the location of the European Union’s agencies is a matter for the European Union. In seeking a new future economic partnership with the EU, we will discuss how best to continue cooperation in the fields of medicines regulation and banking regulation, in the best interests of patients, citizens and business, both in the UK and the EU. Until we have left the EU, the UK remains a member of the EU with all the rights and obligations that membership entails, including full participation in the activities of the Agencies.

This statement has also been made in the House of Lords: HLWS261

Share this page